Premier (NASDAQ:PINC) Issues FY 2025 Earnings Guidance

Premier (NASDAQ:PINC) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 1.260-1.340 for the period, compared to the consensus EPS estimate of 1.290. The company issued revenue guidance of $940.0 million-$1.0 billion, compared to the consensus revenue estimate of $990.8 million.

Premier Stock Down 14.9 %

Shares of PINC stock traded down $3.35 during trading hours on Tuesday, hitting $19.05. 1,609,906 shares of the company’s stock traded hands, compared to its average volume of 1,181,306. The stock’s 50 day simple moving average is $21.91 and its 200 day simple moving average is $20.96. The stock has a market cap of $1.83 billion, a PE ratio of 14.08 and a beta of 0.43. Premier has a 12 month low of $17.95 and a 12 month high of $23.56.

Premier (NASDAQ:PINC) last posted its quarterly earnings data on Tuesday, February 4th. The company reported $0.25 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.04). Premier had a return on equity of 10.74% and a net margin of 11.41%. As a group, equities research analysts expect that Premier will post 1.12 EPS for the current fiscal year.

Premier Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Saturday, March 15th. Shareholders of record on Saturday, March 1st will be issued a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a yield of 4.41%. The ex-dividend date is Friday, February 28th. Premier’s payout ratio is 61.77%.

Analysts Set New Price Targets

PINC has been the subject of a number of research reports. Canaccord Genuity Group raised their price target on shares of Premier from $19.00 to $21.00 and gave the stock a “hold” rating in a report on Wednesday, November 6th. Barclays raised their price target on shares of Premier from $20.00 to $24.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 6th. Robert W. Baird raised their price target on shares of Premier from $19.00 to $20.00 and gave the stock a “neutral” rating in a report on Wednesday, November 6th. Finally, StockNews.com cut shares of Premier from a “buy” rating to a “hold” rating in a report on Tuesday, November 5th. Ten analysts have rated the stock with a hold rating, According to data from MarketBeat, Premier currently has an average rating of “Hold” and an average price target of $21.36.

Insider Activity

In related news, CEO Michael J. Alkire sold 17,415 shares of the firm’s stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $23.16, for a total transaction of $403,331.40. Following the transaction, the chief executive officer now directly owns 520,728 shares of the company’s stock, valued at $12,060,060.48. This trade represents a 3.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Leigh Anderson sold 20,000 shares of the firm’s stock in a transaction dated Friday, December 20th. The shares were sold at an average price of $21.88, for a total transaction of $437,600.00. Following the transaction, the chief operating officer now directly owns 111,707 shares in the company, valued at $2,444,149.16. The trade was a 15.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 59,425 shares of company stock worth $1,320,242 over the last three months. 0.96% of the stock is currently owned by insiders.

Premier Company Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.